Jia Li

Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma

Jae H. Park, M. Lia Palomba, Karlo Perica et al. · Journal of Clinical Oncology · 2025 · 17 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study

Yuting Ma, Fang Hua, Xiuming Zhong et al. · Frontiers in Immunology · 2023 · 14 citations · Full text

Medicine, Oncology, Pathology +17

Exploring the causal relationship between B lymphocytes and Parkinson’s disease: a bidirectional, two-sample Mendelian randomization study

Jia Song, Yidan Qin, Lin Wang et al. · Scientific Reports · 2024 · 12 citations · Full text

Life Sciences, Immunology, Neurology +17

Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial

Xingxiang Pu, Zemin Xiao, Jia Li et al. · Lung Cancer · 2024 · 10 citations · Full text

Medicine, Oncology, Pharmacology +15